BDBM50066103 1N-[1-(1H-3-indolylmethyl)-2-oxo-2-[4-oxo-(2'S)-spiro[3H,4H-chromene-2,3'-(hexahydropyridine)]-1-yl]-(1R)-ethyl]-2-amino-2-methylpropanamide::1N-[1-(1H-3-indolylmethyl)-2-oxo-2-[4-oxo-(2'S)-spiro[4H-chromene-2,3'-(hexahydropyridine)]-1-yl]-(1R)-ethyl]-2-amino-2-methylpropanamide::CHEMBL13926

SMILES CC(C)(N)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@@]2(C1)CC(=O)c1ccccc1O2

InChI Key InChIKey=KXMBIAQXUZZYJL-DFHRPNOPSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50066103   

TargetGrowth hormone secretagogue receptor type 1(Rattus norvegicus)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50066103(1N-[1-(1H-3-indolylmethyl)-2-oxo-2-[4-oxo-(2'S)-sp...)
Affinity DataEC50:  57nMAssay Description:In vitro growth hormone release was determined in rat pituitary cell assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed